70748-355-01 : NDC 2026 Code

70748-355-01 : Rivaroxaban Granule ( Rivaroxaban Granule )

Additionally :

You can get information about “70748-355-01” NDC code in 70748-355-01 in HTML format

HTML | 70748-355-01 in TXT (Plain Text) format

TXT | 70748-355-01 in PDF (Portable Document Format)

PDF | 70748-355-01 in XML format

XML formats.

NDC Code : 70748-355-01 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "70748-355-01",
    "PackageDescription": "1 BOTTLE in 1 CARTON (70748-355-01)  / 1 FOR SUSPENSION in 1 BOTTLE",
    "NDC11Code": "70748-0355-01",
    "ProductNDC": "70748-355",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Rivaroxaban Granule",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Rivaroxaban Granule",
    "DosageFormName": "FOR SUSPENSION",
    "RouteName": "ORAL",
    "StartMarketingDate": "20250929",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA218195",
    "LabelerName": "Lupin Pharmaceuticals, Inc.",
    "SubstanceName": "RIVAROXABAN",
    "StrengthNumber": "155",
    "StrengthUnit": "mg/1",
    "Pharm_Classes": "Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2025-11-12",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20250929",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}